C. Koscik

Fgl2 deficiency causes neonatal death and cardiac dysfunction during embryonic and postnatal development in mice.

M. Mendicino, Wei He, P. Backx, 2007, Physiological genomics.

Targeted Deletion of Fgl-2/Fibroleukin in the Donor Modulates Immunologic Response and Acute Vascular Rejection in Cardiac Xenografts

T. Waddell, M. Mendicino, Wei He, 2005, Circulation.

Targeted delivery of ribavirin improves outcome of murine viral fulminant hepatitis via enhanced anti‐viral activity†

R. Gorczynski, Williams He, I. McGilvray, 2006, Hepatology.

Role of Fibrinogen-Like Protein 2 Prothrombinase/Fibroleukin in Experimental and Human Allograft Rejection1

Q. Ning, Weijie Zhang, R. Gorczynski, 2005, The Journal of Immunology.

Primitive neural stem cells from the mammalian epiblast differentiate to definitive neural stem cells under the control of Notch signaling.

D. van der Kooy, I. Kanazawa, S. Kusunoki, 2004, Genes & development.

Targeted Deletion of fgl2 Leads to Impaired Regulatory T Cell Activity and Development of Autoimmune Glomerulonephritis1

M. Cybulsky, Ming Liu, G. Downey, 2008, The Journal of Immunology.